153 related articles for article (PubMed ID: 32912437)
21. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Wang G; He D; Li X; Li J; Peng Z
Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016
[TBL] [Abstract][Full Text] [Related]
23. Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitors.
Hu Z; Wang C; Sitkoff D; Cheadle NL; Xu S; Muckelbauer JK; Adam LP; Wexler RR; Quan ML
Bioorg Med Chem Lett; 2020 Nov; 30(21):127474. PubMed ID: 32805407
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors.
Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL
Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804
[TBL] [Abstract][Full Text] [Related]
25. Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies.
Iqbal J; al-Rashida M; Babar A; Hameed A; Khan MS; Munawar MA; Khan AF
Med Chem; 2015; 11(5):489-96. PubMed ID: 25537128
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors.
Yuan X; Wu H; Bu H; Zheng P; Zhou J; Zhang H
Bioorg Med Chem; 2019 Apr; 27(7):1211-1225. PubMed ID: 30824167
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors.
Balupuri A; Lee DY; Lee MH; Chae S; Jung E; Kim Y; Ryu J; Kang NS
Bioorg Med Chem Lett; 2017 Sep; 27(17):4156-4164. PubMed ID: 28743508
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Özdemir A
Molecules; 2018 May; 23(6):. PubMed ID: 29857484
[TBL] [Abstract][Full Text] [Related]
30. Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors.
Park H; Lee S; Hong S
Bioorg Med Chem Lett; 2015 Sep; 25(18):3784-7. PubMed ID: 26259807
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
Hou S; Xu H; Hu J; Hou J; Wang Y; Jin Z; Wan DCC; Hu C
Med Chem; 2018; 14(1):67-73. PubMed ID: 28969571
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases.
Deau E; Loidreau Y; Marchand P; Nourrisson MR; Loaëc N; Meijer L; Levacher V; Besson T
Bioorg Med Chem Lett; 2013 Dec; 23(24):6784-8. PubMed ID: 24176400
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).
Mott BT; Tanega C; Shen M; Maloney DJ; Shinn P; Leister W; Marugan JJ; Inglese J; Austin CP; Misteli T; Auld DS; Thomas CJ
Bioorg Med Chem Lett; 2009 Dec; 19(23):6700-5. PubMed ID: 19837585
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of 2-aminothiazole derivatives as sphingosine kinase inhibitors.
Vogt D; Weber J; Ihlefeld K; Brüggerhoff A; Proschak E; Stark H
Bioorg Med Chem; 2014 Oct; 22(19):5354-67. PubMed ID: 25150091
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents.
Yao Y; Li R; Liu X; Yang F; Yang Y; Li X; Shi X; Yuan T; Fang L; Du G; Jiao X; Xie P
Molecules; 2017 Oct; 22(10):. PubMed ID: 29048389
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.
Boland S; Bourin A; Alen J; Geraets J; Schroeders P; Castermans K; Kindt N; Boumans N; Panitti L; Fransen S; Vanormelingen J; Stassen JM; Leysen D; Defert O
J Med Chem; 2015 May; 58(10):4309-24. PubMed ID: 25898023
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
